Press ESC to close

AstraZeneca to Invest $1.5 Billion in Singapore ADC Facility

AstraZeneca PLC (LSE/STO/NASDAQ: AZN), a global biopharmaceutical company, has announced plans to invest $1.5 billion in the construction of a new manufacturing facility dedicated to the production of antibody drug conjugates (ADCs) in Singapore. This initiative marks the company's first venture into the manufacturing sector in Singapore and is expected to be fully operational by 2029.

This facility, which will be the first at AstraZeneca to cover the entire manufacturing process for ADCs, will be supported by the Singapore Economic Development Board (EDB). ADCs represent a significant advancement in oncology treatment as they are designed to deliver powerful cancer-killing agents directly to cancer cells, minimizing damage to healthy cells.

Advancing Cancer Therapy with ADCs

Antibody-drug conjugates (ADCs) are engineered antibodies designed to target and destroy tumor cells by delivering cell-killing chemicals directly to the site. AstraZeneca's investment underscores its commitment to developing innovative cancer treatments and addressing unmet medical needs.

Building a State-of-the-Art Manufacturing Center

This facility will be AstraZeneca's first end-to-end ADC production site, handling all stages of ADC production, from antibody production to final product filling. With construction expected to start by the end of 2024 and operations to begin in 2029, this facility will play a crucial role in AstraZeneca's global manufacturing network.

Commitment to Sustainability and Innovation

AstraZeneca aims to ensure environmental sustainability by committing to zero carbon emissions from day one of the facility's operation. This initiative reflects the company's dedication to responsible manufacturing practices and its contribution to a greener future.

Objective Questions for Competitive Exams

Q.1. What is the main objective of the ChipIN Center?

a) Semiconductor manufacturing 
b) Designing semiconductor chips and IP 
c) Training astronauts

Answer: b) Designing semiconductor chips and IP

Q.2. Where is AstraZeneca's headquarters located?

a) New York 
b) London 
c) Singapore

Answer: b) London

Q.3. What is the full form of ADC?

a) Antibody Drug Conjugate 
b) Automatic Driving Car 
c) Automatic Data Collection

Answer: a) Antibody Drug Conjugate

Q.4. In which field is ADC primarily used?

a) Automotive 
b) Oncology 
c) Education

Answer: b) Oncology

Q.5. What type of company is AstraZeneca?

a) Automobile 
b) IT 
c) Biopharmaceutical

Answer: c) Biopharmaceutical

Related Posts

A New Eel from Tamil Nadu - Meet Apterichtus kanniyakumari
Rare Sighting in Tamil Nadu - Red-Necked Phalarope Turns Up
Semicon Saga: Can India do an NvI(n)DIA?
Giotto.ai: Swiss AI Startup on Track for $1 Billion+ Valuation
Prerna Payal

With a keen eye for storytelling and a deep interest in digital media, Prerna Payal brings over four years of rich experience in communication, training support, and social media strategy. Her journey began in mainstream media with platforms like iNext and CNN-IBN, where she sharpened her skills in content creation and reporting.

Leave a comment

Your email address will not be published. Required fields are marked *

Your experience on this site will be improved by allowing cookies.